XNK Therapeutics appoints Dr. Anna-Karin Maltais as CSO ...Middle East

HUDDINGE, Sweden, Sept. 15, 2022 /PRNewswire/ -- XNK Therapeutics AB ("XNK") today announced the appointment of Dr. Anna-Karin Maltais as Chief Scientific Officer, effective October 17th. She will be a member of the company's management team. Anna-Karin Maltais, PhD, will be responsible...

Hence then, the article about xnk therapeutics appoints dr anna karin maltais as cso was published today ( Thursday 15/09/2022 - 09:40 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( XNK Therapeutics appoints Dr. Anna-Karin Maltais as CSO )

Also on site :

• 'The chances of you living 50 years are very small': Theoretical physicist explains why humanity likely won't survive to see all the forces unified
• The Strokes End Coachella Performance With Video Montage Condemning U.S. and Israeli Bombings in Iran and Gaza
• FBI, DOJ scrambling to rebuild after being depleted by resignations and firings